Enantioselective analysis of mirtazapine and its two major metabolites in human plasma by liquid chromatography–mass spectrometry after three-phase liquid-phase microextraction
Authors:
- Pierina Sueli BonatoPBPierina Sueli Bonato
- 1 January 2008
- journal article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 606 (1) , 80-91
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Therapeutic Drug Monitoring of Mirtazapine, Desmethylmirtazapine, 8-Hydroxymirtazapine, and Mirtazapine-N-oxide by Enantioselective HPLC With Fluorescence DetectionTherapeutic Drug Monitoring, 2006
- New method for the chiral evaluation of mirtazapine in human plasma by liquid chromatographyJournal of Chromatography B, 2004
- Chirality in the New Generation of AntidepressantsTherapeutic Drug Monitoring, 2004
- Alcohol detoxification and social anxiety symptoms: a preliminary study of the impact of mirtazapine administrationJournal of Affective Disorders, 2003
- Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trialBiological Psychiatry, 2003
- In vitro metabolism of mirtazapine enantiomers by human cytochrome P450 enzymesHuman Psychopharmacology: Clinical and Experimental, 2001
- A Review of the Pharmacological and Clinical Profile of MirtazapineCNS Drug Reviews, 2001
- Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Clinical Practice Guidelines for Bipolar Disorder From the Department of Veterans AffairsThe Journal of Clinical Psychiatry, 1999
- Mirtazapine, an antidepressantAmerican Journal of Health-System Pharmacy, 1998